Kazazian Asset Management, LLC Macrogenics Inc Transaction History
Kazazian Asset Management, LLC
- $123 Billion
- Q1 2025
A detailed history of Kazazian Asset Management, LLC transactions in Macrogenics Inc stock. As of the latest transaction made, Kazazian Asset Management, LLC holds 19,236 shares of MGNX stock, worth $25,199. This represents 0.02% of its overall portfolio holdings.
Number of Shares
19,236
Previous 42,036
54.24%
Holding current value
$25,199
Previous $137 Million
82.12%
% of portfolio
0.02%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding MGNX
# of Institutions
133Shares Held
54MCall Options Held
45.1KPut Options Held
143K-
Bellevue Group Ag Kuesnacht, V89.93MShares$13 Million0.29% of portfolio
-
Armistice Capital, LLC New York, NY6.3MShares$8.25 Million0.12% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$7.08 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.43MShares$5.8 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$4.26 Million0.02% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $80.5M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...